The report forecasts the global cancer diagnostics devices market to grow at a CAGR of 18.07% during the period 2016-2020.
The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
A trend which will definitely boost market growth is product approvals and launches. The significant focus on cancer diagnosis has led to the development of novel cancer diagnostic devices in the market. Many of these products have received approval from regulatory agencies such as the FDA and Health Canada. The availability of these advanced tests and associated diagnostic devices has allowed medical facilities to adopt them for cancer diagnosis.
According to the report, a key growth driver is the demand for personalized medicines. The production of personalized drugs depends on the identification and study of protein and gene expressions. These drugs are customized based on an individual's protein or genetic profiles. Personalized medicines have high demand in oncology therapy since conventional cancer drug therapies fail to achieve desired patient outcomes.
Further, the report states that one challenge that could impact market growth is the high cost of developing companion diagnostics.
Key Topics Covered:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Cancer statistics
PART 06: Market landscape
PART 07: Reimbursement and coverage: An overview
PART 08: Cancer diagnostic devices: Pricing scenario